Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Knowing when to revise budget categories is essential for effective financial management. Keep your budget relevant to your needs.
7,562 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Trinity Capital remains a high-yield fixture in venture lending, but a balance of losses, dilution, and rate shifts u...
A conflict over Iran threatens Asia's access to fertilizer and helium, risking farm yields and semiconductor supply c...
Several states weigh gas-tax pauses or rebates to ease rising pump costs, with potential savings of tens of cents per...
A surprise visit to Graceland by a former president coincides with travel chaos and international tensions, rattling ...
When markets tank, investors ask which asset holds up better. This article compares XRP and Shiba Inu to help you dec...
Micron’s stock is dropping amid questions about whether Google's new AI memory efficiency could curb DRAM demand. Her...
This original millionaire interview-style guide dives into the daily habits, smart choices, and concrete steps that h...
In 2026, savvy investors favor dividend stocks that reliably pay and grow. This article highlights two no-brainer div...
AI is changing how and where we work, but the tools ahead disruption already exist to soften the impact. This report ...
Israel launched airstrikes on Iran’s nuclear facilities, drawing Iran’s vow of retaliation and sending tremors throug...
The latest data show the U.S. public debt now tops the nation's GDP, a milestone with potential implications for rate...